BRIEF-Keryx Biopharmaceuticals jumps in premarket after kidney disease drug meets trial goal

NEW YORK Mon Jan 28, 2013 7:32am EST

NEW YORK Jan 28 (Reuters) - Keryx Biopharmaceuticals Inc : * Keryx Biopharma jumps 46.4 percent to $5.02 in premarket after kidney disease drug meets late-stage trial goal

FILED UNDER:
A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article